GPs win back PBS prescribing rights for kids’ asthma drug
Clinicians have welcomed the change, but remaining restrictions are still a cause for concern, says Dr Kerry Hancock.
GPs will be allowed to prescribe subsidised Flixotide Junior and Axotide Junior to young children once more after the PBAC partly reversed its controversial changes.
It means initial scripts for fluticasone propionate 50µg per actuation, 120 actuations, will no longer be restricted to respiratory physicians or paediatricians.
The PBS listing will also move from authority required to streamlined authority required.
But the date this will come into effect is unclear, with the Department of Health and Aged Care and the medications’ sponsor, GSK Australia, still finalising the revised listing details.
